RELAPSED OR REFRACTORY AUTOIMMUNE CYTOPENIAS

Clinical trials for RELAPSED OR REFRACTORY AUTOIMMUNE CYTOPENIAS explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR REFRACTORY AUTOIMMUNE CYTOPENIAS trials appear

Sign up with your email to follow new studies for RELAPSED OR REFRACTORY AUTOIMMUNE CYTOPENIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can an RNA 'Message' reprogram the immune system to stop autoimmune blood disorders?

Disease control Not yet recruiting

This early-stage trial is testing an experimental therapy called RXIM002 in adults with relapsed or refractory autoimmune cytopenias, including immune thrombocytopenia (ITP). The therapy uses a special RNA molecule to instruct the body to produce CAR T cells that target and poten…

Matched conditions: RELAPSED OR REFRACTORY AUTOIMMUNE CYTOPENIAS

Phase: PHASE1 • Sponsor: RiboX Therapeutics Ltd. • Aim: Disease control

Last updated Aug 16, 2026 00:00 UTC

RELAPSED OR REFRACTORY AUTOIMMUNE CYTOPENIAS

Get alerted when new RELAPSED OR REFRACTORY AUTOIMMUNE CYTOPENIAS trials appear

Can an RNA 'Message' reprogram the immune system to stop autoimmune blood disorders?